In a filing, Ironwood Pharmaceuticals Inc revealed its Officer Davis Andrew acquired Company’s shares for reported $0.24 million on Dec 27 ’24. In the deal valued at $4.00 per share,60,434 shares were bought.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Davis Andrew sold 5,360 shares, generating $21,869 in total proceeds. Upon selling the shares at $4.08, the SVP, Chief Business Officer now owns 284,685 shares.
Before that, Emany Sravan Kumar sold 11,001 shares. Ironwood Pharmaceuticals Inc shares valued at $44,884 were divested by the SVP, COO and CFO at a price of $4.08 per share. As a result of the transaction, Emany Sravan Kumar now holds 309,572 shares, worth roughly $1.38 million.
Leerink Partners initiated its Ironwood Pharmaceuticals Inc [IRWD] rating to a Market perform in a research note published on September 09, 2024; the price target was $5. A number of analysts have revised their coverage, including CapitalOne’s analysts, who decreased its forecast for the stock in early August from “an Overweight” to “an Equal weight”. Craig Hallum began covering IRWD with “Buy” recommendation on January 17, 2024. Wells Fargo started covering the stock on December 14, 2023. It rated IRWD as “an Overweight”.
Price Performance Review of IRWD
On Friday, Ironwood Pharmaceuticals Inc [NASDAQ:IRWD] saw its stock fall -3.05% to $4.45. Over the last five days, the stock has gained 14.69%. Ironwood Pharmaceuticals Inc shares have fallen nearly -61.10% since the year began. Nevertheless, the stocks have fallen -61.34% over the past one year. While a 52-week high of $15.70 was reached on 02/14/24, a 52-week low of $3.06 was recorded on 12/06/24. SMA at 50 days reached $4.00, while 200 days put it at $5.68.
Levels Of Support And Resistance For IRWD Stock
The 24-hour chart illustrates a support level at 4.30, which if violated will result in even more drops to 4.15. On the upside, there is a resistance level at 4.61. A further resistance level may holdings at 4.77. The Relative Strength Index (RSI) on the 14-day chart is 61.04, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.59, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 38.57%. Stochastics %K at 70.10% indicates the stock is a holding.
How much short interest is there in Ironwood Pharmaceuticals Inc?
A steep rise in short interest was recorded in Ironwood Pharmaceuticals Inc stocks on 2024-12-13, growing by 3.52 million shares to a total of 12.08 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 8.57 million shares. There was a rise of 29.11%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on November 09, 2023 when Jefferies began covering the stock and recommended ‘”a Buy”‘ rating along with a $21 price target.
